Anna Durbin, MD

Professor
Johns Hopkins Bloomberg School of Public Health

Disclosure(s): Merck & Co.: Advisor/Consultant

Poster(s):

• 2138 - Evaluating the Safety and Immunogenicity of the rZIKV/D4Δ30-713 Live Attenuated Chimeric Zika Candidate Vaccine in Healthy Flavivirus-Naïve Adults
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET